Cowen & Co Upgrades Natus Medical (BABY) to Outperform
More News related to BABY
- natus Medical (BABY) Posts Q3 EPS of $0.13, Tops by 2c; Guides
- Natus Medical Announces 2009 Third Quarter Financial Results and Increases Fourth Quarter and Full Year 2009 Guidance
- Natus Medical to Hold 2009 Third Quarter Financial Results Conference Call on November 2
- Cowen & Co Upgrades Natus Medical (BABY) to Outperform
- Notable Mergers and Acquisitions of the Day 9/14: S/DT, CA, BABY
More News related to Upgrades
- Inergy Holdings (NRGP) Posts Q4 Loss of $0.79, Below Estimates; Guides
- Patriot Transportation (PATR) Posts Q4 EPS of $0.32, MIsses Estimates
- Unify Corporation (UNFY) Posts Q2 non-GAAP EPS of $0.02, Down Y/Y; Revs Higher; Guides
Cowen & Co upgrades Natus Medical (Nasdaq: BABY) from Neutral to Outperform.
To see more analyst ratings on BABY Click Here.
Natus Medical Incorporated develops, manufactures, and markets neurondiagnostic and newborn care products worldwide.
Related Categories
UpgradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
